Targeted agents: the rules of combination.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17875749.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The success of molecularly targeted agents (MTA) in the treatment of cancer has led to the investigation of their use in combination with other MTAs and with conventional chemotherapies. An overview of the MTAs that have emerged as Food and Drug Administration-approved drugs is presented, along with a framework for the consideration of how MTAs can best be combined to maximize therapeutic effect.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Neoplasms